What is NDC 43063-721?

43063-721 is the product NDC for Primaquine Phosphate, Primaquine phosphate 15 mg/1 tablet, listed with the FDA by PD-Rx Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

PD-Rx Pharmaceuticals, Inc., NDC labeler code 43063. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Primaquine Phosphate?

4 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Primaquine Phosphate NDC 43063-721 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)43063-721Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43063-0721Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43063-721-14	43063072114	14 TABLET in 1 BOTTLE, PLASTIC (43063-721-14)Marketed from Oct 17, 2016
43063-721-28	43063072128	28 TABLET in 1 BOTTLE, PLASTIC (43063-721-28)Marketed from Oct 17, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Primaquine Phosphate
Generic name (nonproprietary): primaquine phosphate
Active ingredients: Primaquine phosphate — 15 mg/1
Dosage form: Tablet
Route: Oral
Labeler: PD-Rx Pharmaceuticals, Inc.NDC labeler code 43063
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204476
Marketing start: Aug 1, 2014
Listing expires: Dec 31, 2027
Identifiers: Product ID 43063-721_51a584d0-f172-e260-e063-6394a90a4547SPL ID 51a584d0-f172-e260-e063-6394a90a4547SPL set ID 3f16166d-678e-51aa-e054-00144ff88e88RxCUI 904170UNII H0982HF78BUPC 0343063721285
Pharmacologic class: Antimalarial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443063072114 followed by a unit qualifier and the quantity

Package 43063-0721-14. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 12, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Primaquine phosphate Tablets are indicated for the radical cure (prevention of relapse) of vivax malaria.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 43063-721

What is NDC 43063-721?: 43063-721 is the product NDC for Primaquine Phosphate, Primaquine phosphate 15 mg/1 tablet, listed with the FDA by PD-Rx Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Primaquine Phosphate.
What is the active ingredient?: Primaquine phosphate.
Who is the labeler?: PD-Rx Pharmaceuticals, Inc., NDC labeler code 43063. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Primaquine Phosphate?: 4 other product NDCs are listed under this name. See all Primaquine Phosphate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Primaquine Phosphate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Primaquine Phosphate	Primaquine phosphate 15 mg/1	Tablet, Film coatedOral	AvKARE	42291-510	42291-0510-01
Primaquine Phosphate	Primaquine phosphate 15 mg/1	Tablet, Film coatedOral	Ingenus Pharmaceuticals, LLC	50742-191	50742-0191-0150742-0191-05
Primaquine Phosphate	Primaquine phosphate 15 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	76385-102	76385-0102-01
Primaquine Phosphate	Primaquine phosphate 15 mg/1	Tablet, Film coatedOral	Sanofi-Aventis U.S. LLC	0024-1596	00024-1596-01

Other NDCs under ANDA 204476

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204476
Product	Strength	Form · route	Labeler	Product NDC
Primaquine Phosphate	Primaquine phosphate 15 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	76385-102